Computational modelling of the equine arteritis virus GP5/M Dimer: Implications for immune evasion and virulence.
Authors: Veit Michael, Matczuk Anna Karolina
Journal: PloS one
Summary
# Computational Modelling of Equine Arteritis Virus GP5/M Dimer: Structural Insights for Vaccine Development Equine arteritis virus (EAV), an important respiratory pathogen in the equine industry, relies on its surface glycoprotein dimer (GP5/M) for viral entry and as the primary target for neutralising antibodies, yet the detailed 3D structure of this complex had remained unknown until now. Michael and Matczuk used AlphaFold3 to predict the GP5/M dimer architecture and compare it with the homologous structure in the related porcine reproductive and respiratory syndrome virus (PRRSV), revealing a conserved three-helical transmembrane core but with EAV's distinctive longer ectodomain featuring four α-helices and a disulfide-linked β-sheet that forms the immunologically critical surface-exposed region. The ectodomain proved to be the most variable component and contains key neutralising epitopes, whilst neighbouring N-glycosylation sites—some conserved and others variable—suggest the virus evades immunity through antigenic drift and glycan masking, with an additional epitope in the membrane-proximal helix overlapping known virulence determinants. For equine practitioners involved in vaccination strategy or herd health management, these structural findings provide a rational basis for developing improved EAV vaccines by targeting the identified epitope regions, potentially enhancing protection against both acute infection and the carrier state that complicates disease control in breeding populations. The conservation of transmembrane architecture between EAV and PRRSV also hints at opportunities for cross-protective vaccine platforms, though species-specific validation would be required before clinical application.
Read the full abstract on PubMed
Practical Takeaways
- •Understanding the variable epitope regions and glycan shielding mechanisms of EAV GP5/M may guide development of more effective vaccines that overcome the virus's immune evasion strategies
- •The structural conservation of transmembrane domains across arteriviruses suggests these regions may be promising targets for broad-spectrum antiviral therapeutics
- •Knowledge of virulence-associated epitopes in membrane-proximal helices could inform vaccine design to enhance protective immunity against EAV persistence
Key Findings
- •EAV GP5/M dimer has a conserved architecture with three transmembrane helices and variable ectodomain containing neutralizing epitopes
- •EAV GP5 features a longer ectodomain than PRRSV homolog with four α-helices and disulfide-linked β-sheet forming the most variable, surface-exposed region
- •Adjacent conserved and variable N-glycosylation sites suggest immune evasion through antigenic drift and glycan shielding
- •Transmembrane domains are the most structurally conserved regions between EAV and PRRSV, stabilized by hydrophilic interactions